Examinando por Materia "Meropenem"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Características de uso de meropenem y vancomicina en el servicio de emergencia en pacientes adultos del Hospital Cayetano Heredia. Julio–diciembre 2018
    (Universidad Privada Norbert Wiener, 2020-11-11) Ventura Quispe, Vilma; Velásquez Valverde, Bertha Esther; Caldas Herrera, Emma
    This study aims to characterize the use of meropenem and vancomycin in the emergency service for adult patients at the HCH from July to December 2018. Methodology: A descriptive, cross-sectional retrospective investigation was conducted. Data were collected from 500 records of adult patients treated in the pharmacy service. Results: For drug indication, December showed the highest proportion for meropenem (20.7%), while vancomycin in August reported the highest proportion (19%). The 1 gr administration was the highest proportion for both medications. The main diagnoses for which meropenem and vancomycin were indicated were Soft Tissue Sepsis (10.8%) and Hospital-Acquired Pneumonia (11%). For combination therapy with meropenem and vancomycin, the most common diagnoses were Community-Acquired Pneumonia (14.8%) and Urinary Tract Infection (11.1%). Regarding authorization by infectology consultation, 83% of meropenem use was authorized, while 17% was not. For vancomycin-treated patients, 90% were not authorized by infectology, and 10% were authorized. Conclusion: The study demonstrated that usage characteristics and pharmacovigilance are baseline instruments that should be permanent to identify prescribing patterns in the context of bacterial resistance to both antibiotics.